Sun Pharma beats Street; Q2 net profit rises 2.6%

Sun Pharmaceutical Industries on Wednesday beat Street estimates for the September quarter with a consolidated net profit of %3,117.95 crore, up 2.6% from 3,040.16 crore reported inthe year-ago period. India's largest drugmaker by sales said its revenue from operations rose 8.6% year-on-year (y-0-y) to %14,405.2 crore.

- Jessica Jani & Ankit Gohel

The company witnessed steady revenue growth in most markets. Its generic sales in the US saw a 4% decline to $496 million during the quarter, but this was offset by growth in the innovative portfolio, Sun Pharma said.